| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.4 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |